{"id":52183,"date":"2022-12-20T16:02:36","date_gmt":"2022-12-20T15:02:36","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\/"},"modified":"2022-12-20T16:02:36","modified_gmt":"2022-12-20T15:02:36","slug":"pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\/","title":{"rendered":"Pfizer Invites Public to View and Listen to Webcast of January 31 Conference Call with Analysts"},"content":{"rendered":"
\n

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, January 31, 2023. The purpose of the call is to provide an update on Pfizer\u2019s results, as reflected in the company\u2019s Fourth Quarter and Full Year 2022 Performance Report, to be issued that morning.\n<\/p>\n

<\/a><\/p>\n

\nTo view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com\/investors<\/a>. Information on accessing and registering for the webcast will be available at www.pfizer.com\/investors<\/a> beginning today. Participants are advised to register in advance of the conference call.\n<\/p>\n

\nYou can also listen to the conference call by dialing either 800-456-4352 in the United States and Canada or 785-424-1086 outside of the United States and Canada. The passcode is \u201c51512\u201d.\n<\/p>\n

\nThe transcript and webcast replay of the call will be made available on our web site at www.pfizer.com\/investors<\/a> within 24 hours after the end of the live conference call and will be accessible for at least 90 days.\n<\/p>\n

\nAbout Pfizer: Breakthroughs That Change Patients\u2019 Lives
\n
<\/i><\/b>At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com<\/a>. In addition, to learn more, please visit us on www.Pfizer.com<\/a> and follow us on Twitter at @Pfizer<\/a> and @Pfizer News<\/a>, LinkedIn<\/a>, YouTube<\/a> and like us on Facebook at Facebook.com\/Pfizer<\/a>.\n<\/p>\n

\nDisclosure Notice:<\/i> <\/b>The webcast may include forward-looking statements about, among other things, our anticipated operating and financial performance, reorganizations, business plans, strategy and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, launches, clinical trial results and other developing data, revenue contribution and projections, growth, performance, timing of exclusivity and potential benefits; strategic reviews; capital allocation objectives; dividends and share repurchases; plans for and prospects of our acquisitions, dispositions and other business development activities; and our ability to successfully capitalize on growth opportunities and prospects; manufacturing and product supply; our efforts to respond to COVID-19, including our COVID-19 products; our expectations regarding the impact of COVID-19 on our business, operations and financial results; and other statements about our business, operations and financial results, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. A description of these risks and uncertainties can be found in Pfizer\u2019s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned \u201cRisk Factors\u201d and \u201cForward-Looking Information and Factors That May Affect Future Results\u201d, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at <\/i>www.sec.gov<\/i><\/a> and <\/i>www.pfizer.com<\/i><\/a>.<\/i>\n<\/p>\n

\nThe forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.<\/i>\n<\/p>\n

\nCategory: Finance\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia:
\n
PfizerMediaRelations@Pfizer.com<\/a>
+1 (212) 733-1226\n<\/p>\n

\nInvestors:
\n
IR@Pfizer.com<\/a>
+1 (212) 733-4848\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, January 31, 2023. The purpose of the call is to provide an update on Pfizer\u2019s results, as reflected in the company\u2019s Fourth Quarter … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52183","6":"format-standard","7":"category-industry"},"yoast_head":"\nPfizer Invites Public to View and Listen to Webcast of January 31 Conference Call with Analysts - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer Invites Public to View and Listen to Webcast of January 31 Conference Call with Analysts - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, January 31, 2023. The purpose of the call is to provide an update on Pfizer\u2019s results, as reflected in the company\u2019s Fourth Quarter ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-20T15:02:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221220005212\/en\/1045874\/21\/Pfizer_Logo_Color_RGB_APPROVED.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Pfizer Invites Public to View and Listen to Webcast of January 31 Conference Call with Analysts\",\"datePublished\":\"2022-12-20T15:02:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\\\/\"},\"wordCount\":680,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221220005212\\\/en\\\/1045874\\\/21\\\/Pfizer_Logo_Color_RGB_APPROVED.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\\\/\",\"name\":\"Pfizer Invites Public to View and Listen to Webcast of January 31 Conference Call with Analysts - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221220005212\\\/en\\\/1045874\\\/21\\\/Pfizer_Logo_Color_RGB_APPROVED.jpg\",\"datePublished\":\"2022-12-20T15:02:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221220005212\\\/en\\\/1045874\\\/21\\\/Pfizer_Logo_Color_RGB_APPROVED.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221220005212\\\/en\\\/1045874\\\/21\\\/Pfizer_Logo_Color_RGB_APPROVED.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pfizer Invites Public to View and Listen to Webcast of January 31 Conference Call with Analysts\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pfizer Invites Public to View and Listen to Webcast of January 31 Conference Call with Analysts - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\/","og_locale":"en_US","og_type":"article","og_title":"Pfizer Invites Public to View and Listen to Webcast of January 31 Conference Call with Analysts - Pharma Trend","og_description":"NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, January 31, 2023. The purpose of the call is to provide an update on Pfizer\u2019s results, as reflected in the company\u2019s Fourth Quarter ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\/","og_site_name":"Pharma Trend","article_published_time":"2022-12-20T15:02:36+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221220005212\/en\/1045874\/21\/Pfizer_Logo_Color_RGB_APPROVED.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Pfizer Invites Public to View and Listen to Webcast of January 31 Conference Call with Analysts","datePublished":"2022-12-20T15:02:36+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\/"},"wordCount":680,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221220005212\/en\/1045874\/21\/Pfizer_Logo_Color_RGB_APPROVED.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\/","url":"https:\/\/pharma-trend.com\/en\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\/","name":"Pfizer Invites Public to View and Listen to Webcast of January 31 Conference Call with Analysts - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221220005212\/en\/1045874\/21\/Pfizer_Logo_Color_RGB_APPROVED.jpg","datePublished":"2022-12-20T15:02:36+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221220005212\/en\/1045874\/21\/Pfizer_Logo_Color_RGB_APPROVED.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221220005212\/en\/1045874\/21\/Pfizer_Logo_Color_RGB_APPROVED.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/pfizer-invites-public-to-view-and-listen-to-webcast-of-january-31-conference-call-with-analysts\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Pfizer Invites Public to View and Listen to Webcast of January 31 Conference Call with Analysts"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52183","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52183"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52183\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52183"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52183"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52183"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}